Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Ophthalmology

Building Your Care Team and Preparing for Appointments

At a Glance

To effectively manage Central Areolar Choroidal Dystrophy (CACD), patients should build a specialized care team including an Inherited Retinal Disease (IRD) specialist, an ocular genetic counselor, and a low vision specialist. Preparing a detailed family history and gathering previous eye scans is crucial for your first appointment.

Because Central Areolar Choroidal Dystrophy (CACD) is a rare, genetic condition, your “standard” eye doctor may not have the specialized tools or experience needed to manage it long-term. Building a care team that understands the nuances of inherited retinal diseases (IRDs) is the most important step you can take toward maintaining your independence and accessing future treatments [1][2].

Your Core Specialized Team

Managing an IRD requires a multi-disciplinary approach. You aren’t just looking for one doctor; you are building a small “board of advisors” for your vision.

  • Inherited Retinal Disease (IRD) Specialist: This is an ophthalmologist who has completed extra training (a fellowship) specifically in genetic retinal diseases. They are experts in clinical phenotyping—the art of matching what they see in your eye with a specific genetic cause [1][3].
  • Ocular Genetic Counselor: This specialist helps you navigate the complexities of genetic testing. They interpret your results, explain the inheritance patterns for your children, and help you find clinical trials that match your specific mutation [4][5].
  • Low Vision Specialist: An optometrist with specialized training in helping people make the most of their remaining vision. They prescribe the high-tech magnifiers and lighting tools that a standard eye clinic typically doesn’t carry [6].

Preparing for Your First Consultation

The first visit with an IRD specialist can be intensive. To get the most out of it, you should arrive prepared with a “dossier” of your medical history.

  • Detailed Family Tree: Before your visit, talk to relatives. Note who had vision loss, what they were told the cause was (even if it was “bad cataracts” or “old age”), and the age their symptoms started. Ask specifically if any relatives have ever had genetic testing for an eye condition or participated in a clinical trial, as finding an existing family mutation can dramatically speed up your own diagnostic process [7][8].
  • Previous Imaging: If you have had OCT or FAF scans at other offices, request the digital files (DICOM format) or high-quality printouts to bring with you. Seeing how your retina has changed over time is invaluable for your new specialist [9][10].
  • Genetic Reports: If you have already had any genetic testing done, bring the full lab report, not just a summary letter [11][12].

Evaluating a Potential Specialist

Don’t be afraid to “interview” a new doctor. A qualified IRD specialist will welcome your engagement. You can assess their expertise by asking:

  • “Do you regularly use multimodal imaging (like FAF and OCT-A) to monitor disease progression?” [9][13]
  • “Are you comfortable ordering and interpreting broad-panel genetic testing for PRPH2 or CDHR1 mutations?” [14][15]
  • “Do you have access to specialized diagnostic tools like electrophysiology (ERG)?” [9][16]

The Path to a Molecular Diagnosis

The ultimate goal of your care team is to move from a clinical diagnosis (what your eyes look like) to a molecular diagnosis (what your DNA says) [8]. This is critical because many emerging therapies are “gene-specific,” meaning they are only available to patients with a confirmed mutation in a particular gene [4][11]. Your specialized team will work together to ensure you have the right tests and the right support to understand what those results mean for your life and your family [2][17].

Return to Home Page

Common questions in this guide

What type of doctor treats Central Areolar Choroidal Dystrophy?
Because CACD is a rare genetic condition, it is best managed by an Inherited Retinal Disease (IRD) specialist. This is an ophthalmologist with advanced fellowship training specifically in genetic eye diseases.
How should I prepare for my first CACD specialist appointment?
You should bring a detailed family medical history, specifically noting any relatives with vision loss. It is also crucial to bring digital files or high-quality printouts of previous eye imaging scans, like OCT or FAF, and any prior genetic testing reports.
Why do I need to see a genetic counselor for CACD?
An ocular genetic counselor helps you navigate the complexities of genetic testing for CACD. They interpret your test results, explain inheritance patterns for your family, and can help match you with appropriate clinical trials.
What is the difference between a clinical and molecular diagnosis for CACD?
A clinical diagnosis is based on what your doctor sees when examining your retina. A molecular diagnosis confirms the exact genetic mutation in your DNA causing the disease, which is necessary for accessing many emerging gene-specific treatments.
What does a low vision specialist do for CACD patients?
A low vision specialist is an optometrist with specialized training to help you make the most of your remaining vision. They prescribe high-tech magnifiers, specific lighting tools, and other aids that standard eye clinics typically do not carry.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What percentage of your practice is dedicated specifically to inherited retinal diseases (IRDs)?
  2. 2.Do you have a genetic counselor on staff or a specialized ocular genetics clinic you partner with?
  3. 3.Which specific imaging and functional tests (like ERG or FAF) do you consider essential for monitoring my CACD?
  4. 4.How do you keep up with the latest research and clinical trials specifically for PRPH2 or other CACD-related mutations?
  5. 5.Can you help me coordinate my care with a low-vision specialist and a genetic counselor?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Tapetal-like sheen as a key phenotypical feature in TTLL5-associated cone dystrophy caused by a novel variant.

    Zhai Y, Kodida R, Ballios BG

    American journal of ophthalmology case reports 2025; (39()):102360 doi:10.1016/j.ajoc.2025.102360.

    PMID: 40535326
  2. 2

    An interdisciplinary Inherited Retinal Disease clinic improves time to genetic diagnosis and access to genetics services.

    Goldin MR, Suh H, Kessler C, et al.

    Ophthalmic genetics 2026; (47(3)):268-274 doi:10.1080/13816810.2026.2624617.

    PMID: 41730754
  3. 3

    Molecular and phenotypic investigation of a New Zealand cohort of childhood-onset retinal dystrophy.

    Hull S, Kiray G, Chiang JP, Vincent AL

    American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(3)):708-717 doi:10.1002/ajmg.c.31836.

    PMID: 32856788
  4. 4

    Expanding the Mutation Spectrum for Inherited Retinal Diseases.

    Lynn J, Huang SJ, Trigler GK, et al.

    Genes 2024; (16(1)) doi:10.3390/genes16010032.

    PMID: 39858579
  5. 5

    Exome Sequencing Identified Molecular Determinants of Retinal Dystrophies in Nine Consanguineous Pakistani Families.

    Tehreem R, Chen I, Shah MR, et al.

    Genes 2022; (13(9)) doi:10.3390/genes13091630.

    PMID: 36140798
  6. 6

    Interventions Within the Scope of Occupational Therapy Practice to Improve Performance of Daily Activities for Older Adults With Low Vision: A Systematic Review.

    Liu CJ, Chang MC

    The American journal of occupational therapy : official publication of the American Occupational Therapy Association 2020; (74(1)):7401185010p1-7401185010p18 doi:10.5014/ajot.2020.038372.

    PMID: 32078506
  7. 7

    Exploring the Genetic Causes of Nonsyndromic Retinal Dystrophies in Qatar.

    Abiib S, Khodjet-El-Khil H, Bux RI, et al.

    Genes 2025; (16(12)) doi:10.3390/genes16121415.

    PMID: 41465088
  8. 8

    Molecular and clinical analysis of 27 German patients with Leber congenital amaurosis.

    Weisschuh N, Feldhaus B, Khan MI, et al.

    PloS one 2018; (13(12)):e0205380 doi:10.1371/journal.pone.0205380.

    PMID: 30576320
  9. 9

    Utility of multimodal imaging in the clinical diagnosis of inherited retinal degenerations.

    Lee BJH, Sun CZY, Ong CJT, et al.

    Taiwan journal of ophthalmology 2024; (14(4)):486-496 doi:10.4103/tjo.TJO-D-24-00066.

    PMID: 39803408
  10. 10

    Wide-field fundus autofluorescence imaging in patients with hereditary retinal degeneration: a literature review.

    Oishi A, Miyata M, Numa S, et al.

    International journal of retina and vitreous 2019; (5(Suppl 1)):23 doi:10.1186/s40942-019-0173-z.

    PMID: 31890285
  11. 11

    Artificial intelligence for diagnosis of inherited retinal disease: an exciting opportunity and one step forward.

    Tan TE, Chan HW, Singh M, et al.

    The British journal of ophthalmology 2021; (105(9)):1187-1189 doi:10.1136/bjophthalmol-2021-319365.

    PMID: 34031045
  12. 12

    Genetic Diagnosis for 64 Patients with Inherited Retinal Disease.

    Lynn J, Raney A, Britton N, et al.

    Genes 2022; (14(1)) doi:10.3390/genes14010074.

    PMID: 36672815
  13. 13

    Retinal Thickness Analysis Using Optical Coherence Tomography: Diagnostic and Monitoring Applications in Retinal Diseases.

    Ahn SJ

    Diagnostics (Basel, Switzerland) 2025; (15(7)) doi:10.3390/diagnostics15070833.

    PMID: 40218183
  14. 14

    New genetic diagnoses for inherited retinal dystrophies by integrating splicing tools into NGS pipelines.

    Fernández-Suárez E, González-Del Pozo M, Méndez-Vidal C, et al.

    NPJ genomic medicine 2025; (10(1)):52 doi:10.1038/s41525-025-00500-9.

    PMID: 40603303
  15. 15

    Multidisciplinary team directed analysis of whole genome sequencing reveals pathogenic non-coding variants in molecularly undiagnosed inherited retinal dystrophies.

    Daich Varela M, Bellingham J, Motta F, et al.

    Human molecular genetics 2023; (32(4)):595-607 doi:10.1093/hmg/ddac227.

    PMID: 36084042
  16. 16

    Morpho-functional survey in children suspected of inherited retinal dystrophies via video recording, electrophysiology and genetic analysis.

    Ruberto G, Guagliano R, Barillà D, et al.

    International ophthalmology 2020; (40(10)):2523-2534 doi:10.1007/s10792-020-01432-2.

    PMID: 32507954
  17. 17

    Benefits, limitations, and impacts of reproductive carrier screening and telehealth-based genetic counseling for individuals with an increased chance to have a child with a genetic condition.

    Hardy MW, Bruder K, Rosen A, et al.

    Journal of genetic counseling 2025; (34(3)):e70002 doi:10.1002/jgc4.70002.

    PMID: 40331712

This page provides information on finding specialists and preparing for appointments for Central Areolar Choroidal Dystrophy (CACD) for educational purposes only. Always consult with a qualified eye care professional for medical advice and care coordination.

Get notified when new evidence is published on Central areolar choroidal dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.